Laboratorios Farmacéuticos Rovi SA (0ILL)
LSE
Closed
Oct 8, 2026
Day's Range
58.2052 wk Range
52.45Overview - 0ILL - Laboratorios Farmacéuticos Rovi SA
Key Statistics
Valuation
Enterprise Value
2.93B
P/E (Trailing)
0.17
PEG Ratio
0.0030
Price / Sales (TTM)
0.0010
Price / Book
4.21
EV / EBITDA
16.67
Profitability
Gross Margin
29.57%
Profit Margin
23.95%
Operating Margin
9.41%
Return on Assets
9.44%
Return on Equity
28.65%
Ownership
Shares Outstanding
49.30M
Float
16.20M
Held by Insiders
68.19%
Held by Institutions
16.76%
Price stats
Beta
0.23
50-Day Avg
67.54
200-Day Avg
53.85
Dividends
Frequency
Annual
Market Cap - 0ILL - Laboratorios Farmacéuticos Rovi SA
Peers - 0ILL - Laboratorios Farmacéuticos Rovi SA
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.
Profile Summary - 0ILL - Laboratorios Farmacéuticos Rovi SA
About
Laboratorios Farmacéuticos Rovi SA is a Spanish biotechnology and pharmaceutical company specializing in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. Founded in 1946, it operates through two primary segments: Manufacturing, focused on contract development and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
